Research and Development

Showing 15 posts of 9607 posts found.

New EU Cosmetics Regulation

December 7, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Cosmetics Directive has been recast and the new legislation takes the form of Regulation 1223/2009.  As a Regulation, …

Roche unveils Zurich translational partnership

December 7, 2011 Research and Development Roche, Zurich, academic alliance, translational research

Roche has unveiled a new research collaboration with academic researchers and leading clinical centres in Switzerland. The Basel-based pharma company …
lamattinalee

Big pharma: big rewards come from big risks

December 5, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, R&D productivity

John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …

AstraZeneca to freely share drug compounds with UK groups

December 5, 2011 Research and Development, Sales and Marketing AstraZeneca, research

AstraZeneca will make 22 of its compounds available free of charge to UK academia next year as part of a …

Roche’s Lung cancer test approved for Europe

December 5, 2011 Research and Development, Sales and Marketing Roche, Tarceva, lung cancer

A new test which should help to better target treatment of patients with non-small cell lung cancer (NSCLC) has received …

UK unveils initiatives to support life sciences

December 5, 2011 Research and Development, Sales and Marketing ABPI, UK, competitiveness, david cameron

The government has unveiled plans to help support the UK’s life science industries.The new package of measures includes £180 million …

Europe’s €80 billion will support research

December 2, 2011 Research and Development, Sales and Marketing European Commission

The European Commission has created a new €80 billion budget in an effort to encourage research and innovation across the …

Merck KGaA appoints new heads of corporate auditing and strategy

December 2, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA

Merck KGaA has appointed Dr Friederike Rotsch as its new head of corporate auditing. She reports to Karl-Ludwig Kley, chairman …

Biocartis appoints Dr Nayan Gregory Parekh as its new chief executive

December 1, 2011 Business Services, Research and Development, Sales and Marketing Biocartis

Biocartis, a Swiss company developing compact molecular diagnostic systems, has announced the appointment of Dr Nayan Gregory Parekh as its …
richard_ashcroft

Eli Lilly appoints Richard Ascroft as senior director for the ACE region

November 30, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly

Lilly has appointed Richard Ascroft as senior director, corporate affairs, for the Australia, Canada and Europe (ACE) region. His tasks …
Roche picture

Roche inks $490 million deal with PTC Therapeutics

November 30, 2011 Research and Development, Sales and Marketing PTC Therapeutics, Roche

Roche has signed a $490 million deal with specialist biotech firm PTC Therapeutics. Roche is paying PTC $30 million upfront …

Cerenis appoints John Paolini as chief medical officer

November 29, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cerenis

The HDL drug specialist Cerenis Therapeutics has appointed Dr John Paolini as its new chief medical officer. Dr Paolini will …
Abbott picture

Abbott expands diagnostic pact with GlaxoSmithKline

November 29, 2011 Research and Development, Sales and Marketing Abbott, Cancer, GSK, non-small cell lung cancer

Abbott will develop a diagnostic kit for GlaxoSmithKline’s new lung cancer drug candidate.   This is an expansion of a …

UCB appoints Peter Theil as head of non-clinical development

November 28, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB

Peter Theil has joined UCB as its new vice president and head of non-clinical development for the firm’s new medicines …

The changing of the guard – Q3 round up

November 25, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy

 PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …
The Gateway to Local Adoption Series

Latest content